Search

interesting - search results

If you're not happy with the results, please do another search

0 332

Donald Trump has just chosen Indiana Gov. Mike Pence as his vice presidential running mate, proving bad news for those who hoped for a cannabis policy reform during the next presidency. Indiana still holds draconian drug laws, where possession of any amount of cannabis is still punishable by a $1,000 fine and 180 days in jail. House Bill 1006 was introduced in 2013 as an effort to overhaul Indiana’s criminal code. A clause in the article called for lowering marijuana possession charges, where Pence refused to accept the lowered penalties and demanded a bump back up to a Class B misdemeanor for cannabis possession. Indiana’s archaic drug laws haven’t been updated partly because of Pence’s belief that cannabis is a gateway drug.

Pence’s belief goes against both scientific research and the opinions of Indiana’s majority, who in October 2012 favored for decriminalization in the Indiana Battleground Poll posed by Howey-Depauw. Interestingly, one of Pence’s more controversial laws opened the doors for a minor marijuana victory. Indiana’s Religious Freedom Restoration Act protected religious liberties and was protested by many objectors as an excuse to discriminate against the LGBTQ community. However, the same day Pence signed the bill into law, cannabis activist Bill Levin established the First Church of Cannabis, as a protected religious group that allowed members to partake in cannabis as a religious sacrament despite its illegality within the state.

Trump has wavered between support for cannabis legalization and condemning recreational use. With Pence by his side, Trump’s opinion could possibly change. Although vice-presidential powers are generally limited to tie-breaking votes in the U.S Senate, a running mate’s voice could be powerful and influential. With Pence by his side, there’s a distinct possibility that Trump’s opinion could change. Although vice presidential powers are usually limited to tie-breaking votes in the U.S. Senate, the voice of a running mate can be powerful and influential. Pence’s anti-cannabis rhetoric could impact the future of Trump’s campaign, and might influence the administration’s drug policy if Trump were to be elected.

0 511

Prescription drug prices are still increasing, forcing consumers into more of a struggle. Some older Americans seem to be looking for a different medicine that has been more easily obtainable and legal throughout the country. Research put out on Wednesday showed that some states that legalized medical cannabis, which is common for symptoms such as anxiety or depression, saw a drop in the amount of Medicare prescriptions for drugs used to treat similar conditions as well as a decrease int he amount of spending by Medicare Part D, which covers costs for prescription drugs.

Since the prescriptions for drugs such as opioid painkillers as well as antidepressants dropped in states where cannabis can be legally obtained and used as a replacement, the researchers stated that it seems likely legalization led to a decrease in prescriptions. This is especially noted because prescriptions did not drop for medicines where marijuana can not replace the drug. The study, which was published in Health Affairs, looked at data from Medicare Part D from 2010 to 2013. This is the first study to look at whether or not legalization can impact a doctor’s clinical practice and how it affects health costs.

The results are interesting in terms of the debate as more officials are showing interest in medical cannabis. This year, Ohio, as well as Pennsylvania, passed laws allowing the drug for therapeutic reasons, making it legal in twenty-five states as well as Washington D.C. Ballots in November could increase this number; Florida and Missouri are of the states voting on the issue this autumn. A federal agency is thinking about reclassifying medical cannabis under national drug policy in order to make it more readily available. Medical marijuana saved Medicare approximately $165 million in 2013, the researchers stated. They projected that, if medical cannabis were available throughout the country, Medicare Part D spending would have dropped in the same year by nearly $470 million. That is almost fifty percent of the program’s total spending.

0 908

Friday’s (6/24) MarijuanaStocks Alert Is…
Advantis Corporation (ADVT)

 

How’s your day going? #Brexit fears have had ZERO impact on our new alert, ADVT In fact unlike many of the banking stocks, ADVT has actually been “banking” in a big way after quickly becoming a sub-penny that has now solidified its place above the 0.01 mark. Right now we see ADVT trending with heavy momentum making new highs of $0.0124 and stretching an already 100% win even higher…does this remind you of something?

Like we said last night, we don’t do a whole lot of “alerts” but when we find something that’s under the radar and has enough going on in the company that could become a catalyst, we like to bring some attention to it and so far today ADVT has begun to really wake up…and the last time we brought a sub penny MJ “alert” in front of everyone we saw it run from sub levels all the way to the low THIRTY CENT range. This could be just the very early beginning for ADVT in our opinion as we continue to have “High” expecations for the low pps MJ company.

If you’re just pulling this up for the first time, we’ve kept the full report below. ADVT has quickly caught attention today in a market where everything else is red. A little GREEN from the MJ space doesn’t seem to have hurt too much either and this could be well on its way to continuing the GREEN trend. Stay Tuned!

——————————————————

 

Who Is ADVT?

 

The company has most recently begun focusing on the medical marijuana industry. Earlier this year, ADVT partnered with Natural Elements, Inc. to supply the mutual benefit corporation with all the tools necessary to support its business. The medical marijuana business in California is limited to non-profit organizations comprised of member-patients that have received a prescription for marijuana from their doctor.

ADVT will be supplying Natural Elements Inc. with all necessities required to facilitate their organization’s growth and delivery process to its member-patients. ADVT will supply Natural Elements with agricultural equipment, packaging materials, product delivery solutions, and has put a cross-consulting arrangement in place.

ADVT will be looking to supply additional cooperatives in California, while it works to scale a more profitable business model through its partners (from seed to sale) in states like Oregon and Washington, where this medicine is fully legalized. Further to this ADVT announced JUST THIS MONTH that they’ve engaged in a letter of intent with Hemp2Health, LLC to provide high grade CBD oil extract for ADVT‘s product lines.

And here’s probably one of the most interesting things going on with ADVT: They announced THIS WEEK that they’re going to sub-license N2 Pack’s patented packaging technology to marijuana dispensaries. N2 Packaging Systems LLC has developed a packaging system that hermetically seals cans for freshness, longer shelf life and target branding. ADVT has secured rights to a packaging machine and license to sub-license the product and process to California, Oregon, and Washington marijuana dispensaries. And with built in RFID devices, N2 Pack technology allows suppliers to track, store and market their products to dispensaries and consumers.

 

Why “Alert” This Now?

 

Similar to what we saw at the early stages of our last sub-penny MJ alert…this is a company in the infancy stages of development. They’ve got agreements in place, licensing rights, and a nice LOI from earlier this month so it would appear that there could be a lot coming by way of confirming the progress of all of these building blocks that have been put into place.

Obviously we have “High” expectations and this could quickly become a technical speculation play that turns into something much bigger (those who saw the 0.004 to 0.32 run know what we mean). So in short, why alert this now? It’s at very low levels and there’s a lot that has started to happen with the company…these could be VERY STRONG catalysts heading into Friday morning and potentially beyond. With the way the rulings are planning to change for the scheduling of Marijuana and the upcoming elections, this could become a VERY IMPORTANT time to be watching lower level marijuana stocks.

So what do you do next? Simply put, if you are planning to be active Friday (6/24) morning, BE READY…we’ve kept our eye on this for a few weeks now and as we said above, we have “HIGH” expectations for ADVT. If this hits anywhere NEAR our last profiled sub penny mj alert, this could end up being one of the biggest alerts we see all year!

 

Want Our Updates Faster? Text the phrase “MJStocks” to 82257 Now & Start Getting Messages Sent Straight To Your Cell Phone

 

2 1220

 

Advantis Corporation (ADVT)

 

The cat’s out of the bag. Friday’s (6/24) MJStocks alert in Advantis Corporation (ADVT). As you’ll see, this is a very low priced stock trading under $0.01 and if anyone remembers our last alert on a company that traded under the $0.01 mark from one of the very few times we actually made a formal alert…that ended up running to highs of $0.32. Enough about history lessons though because it’s time to get down to business.

 

Who Is ADVT?

 

The company has most recently begun focusing on the medical marijuana industry. Earlier this year, ADVT partnered with Natural Elements, Inc. to supply the mutual benefit corporation with all the tools necessary to support its business. The medical marijuana business in California is limited to non-profit organizations comprised of member-patients that have received a prescription for marijuana from their doctor.

ADVT will be supplying Natural Elements Inc. with all necessities required to facilitate their organization’s growth and delivery process to its member-patients. ADVT will supply Natural Elements with agricultural equipment, packaging materials, product delivery solutions, and has put a cross-consulting arrangement in place.

ADVT will be looking to supply additional cooperatives in California, while it works to scale a more profitable business model through its partners (from seed to sale) in states like Oregon and Washington, where this medicine is fully legalized. Further to this ADVT announced JUST THIS MONTH that they’ve engaged in a letter of intent with Hemp2Health, LLC to provide high grade CBD oil extract for ADVT‘s product lines.

And here’s probably one of the most interesting things going on with ADVT: They announced THIS WEEK that they’re going to sub-license N2 Pack’s patented packaging technology to marijuana dispensaries. N2 Packaging Systems LLC has developed a packaging system that hermetically seals cans for freshness, longer shelf life and target branding. ADVT has secured rights to a packaging machine and license to sub-license the product and process to California, Oregon, and Washington marijuana dispensaries. And with built in RFID devices, N2 Pack technology allows suppliers to track, store and market their products to dispensaries and consumers.

 

Why “Alert” This Now?

 Similar to what we saw at the early stages of our last sub-penny MJ alert…this is a company in the infancy stages of development. They’ve got agreements in place, licensing rights, and a nice LOI from earlier this month so it would appear that there could be a lot coming by way of confirming the progress of all of these building blocks that have been put into place.

Obviously we have “High” expectations and this could quickly become a technical speculation play that turns into something much bigger (those who saw the 0.004 to 0.32 run know what we mean). So in short, why alert this now? It’s at very low levels and there’s a lot that has started to happen with the company…these could be VERY STRONG catalysts heading into Friday morning and potentially beyond. With the way the rulings are planning to change for the scheduling of Marijuana and the upcoming elections, this could become a VERY IMPORTANT time to be watching lower level marijuana stocks.

So what do you do next? Simply put, if you are planning to be active Friday (6/24) morning, BE READY…we’ve kept our eye on this for a few weeks now and as we said above, we have “HIGH” expectations for ADVT. If this hits anywhere NEAR our last profiled sub penny mj alert, this could end up being one of the biggest alerts we see all year! Stay tuned.

0 775
NYPD Commissioner Bill Bratton announced on a radio show over the last weekend that cannabis is responsible for most of the violence in New York. He added that it baffles him that states want to legalize marijuana.
“Interestingly enough here in New York City, most of the violence we see — violence around drug trafficking — is involving marijuana,” Bratton added. “Here in New York the violence we see associated with drugs, the vast majority of it, is around marijuana, which is ironic considering the explosion in the use of heroin now in the city. I have to scratch my head as we are seeing many states wanting to legalize marijuana or more liberalization of policies.”
Morgan Fox, from the Marijuana Policy Project said to ThinkProgress that his claims are “extremely dubious,” and would be very based on exactly what “involving marijuana” means.
“It seems to me that that statement could only be true if you just count the mere presence of marijuana,” Fox added. “The mere presence of a small amount of marijuana at a crime scene or on the person of someone involved in a violent crime does not mean that marijuana was involved in or the motivation for that crime.”
Because of how crime typically plays out in New York, saying that most of it is because of marijuana would be a bit of a stretch. Crime data, thanks to the multiple pieces involved, such as levels of income to just coincidence, are very difficult to analyze. However, one thing that can be sure is that the cause of crimes cannot just be attributed to one reason, especially not marijuana.
In fact, studies have indicated multiple times that cannabis does not result in violence. Alcohol, which is legal, is very much more likely to result in violence and aggression. Various studies have also indicated that cannabis is less addictive than alcohol and that alcohol is actually worse for you than marijuana. Furthermore, a study from the University of Texas states that legalization might even decrease violent crime rates.

0 1158

Even though medical marijuana is legal in 24 states and recreational cannabis initiatives are gaining traction throughout the U.S., weed is still a touchy topic for most in the medical profession. Sure, some trusted doctors will talk openly about marijuana’s legitimacy as medicine – and many more are coming on board – but journalists’ interview requests to major hospitals and medical schools are still met with a nervous, “Uh, we can’t talk about that on the record.” Which is why Walgreens’ latest Tumblr post is so remarkable.
Walgreens, the largest drug retailing chain in the U.S. with more than 8,000 stores in all 50 states, is now tackling the subject of medical marijuana. Right above a recipe for “All natural fruit roll-ups” on Walgreens’ Tumblr is the headline: “What is medical marijuana?” And its tone is surprisingly sane and straightforward, especially for one of the largest pharmacies in the world.

“The healing properties of marijuana are due to its high cannabidiol content,” the Walgreens blog post reads.

“Marijuana also contains tetrahydrocannabinol, a molecule that can stimulate appetite, decrease nausea, reduce pain and produce a psychoactive effect.”

The post, written by Dahlia Sultan – a resident at the University of Illinois at Chicago’s College of Pharmacy – talks plainly about cannabis’ dangers: “Research has indicated it may impair your lungs, memory, and judgment.” But it also addresses the medical conditions marijuana has been proven to successfully treat.

“Research has also shown marijuana provides pain relief in ways traditional pain medicines don’t. Medical marijuana can improve appetite and relieve nausea in those who have cancer and it may help relieve symptoms such as muscle stiffness in people who have multiple sclerosis.”

We’ve written about many of these studies, and we also covered the Journal of the American Medical Association’s 2015 analysis that showed cannabis as a legitimate treatment for some ailments – including severe pain, nausea, and vomiting related to chemotherapy and spasticity from multiple sclerosis – while its efficacy regarding most conditions is unproven in part because of research blockades.
For America’s largest retailer of pharmaceuticals to speak this straightforwardly about cannabis certainly signals a sea change. The Walgreens blog encourages readers, “If you’d like more information about the use of medical marijuana, talk with your doctor.”

As cannabis financial analyst Alan Brochstein points out in New Cannabis Ventures, “I can’t recall any S&P 500 company ever sharing such a supportive view, especially one that is involved in the lives of so many people who count on it for advice on health and wellness.”
The last line of the Walgreens blog points out an interesting if obvious fact: “Disclaimer: Walgreens is not a licensed medical marijuana provider.” Perhaps the company recognizes that – as cannabis-derived prescription drugs continue their march toward possible FDA approval – that won’t always be the case ?

10 69159

Arkansas may surprisingly be the first state in the South to legalize marijuana. Although this seems ridiculous and to some even unlikely, cannabis proponents learned this week that their bill looking to legalize marijuana in the state now may be plausible before voters get their vote in November. This week, after turning down a proposed ballot initiative almost ten times, the Arkansas Attorney General, Leslie Rutledge, finally signed the initiative that would allow “cultivation, production, distribution, sale, possession, and use of the cannabis plant and cannabis-related products” recreationally as well as medically.

The Arkansas Cannabis Amendment (ACA), which was proposed by Summit resident Mary Berry, may be one of the most thorough cannabis ballot measures to ever come about over the last twenty years in the United States. That is because instead of isolating a certain portion of cannabis smokers, the initiative looks just to end the state’s prohibition by allowing all adults aged twenty-one or older to use cannabis where they believe it would suit them best.

“It’s going to be treated very similar to alcohol,” Don Lane of Arkansas True Grass said in an interview. “The medicinal people will get what they need, the people who like to sit down and have a beer on the weekends can sit down and have some cannabis on the weekends.”

The proposed ballot initiative indicates that cannabis would be sold throughout Arkansas in retail outlets. Each transaction on recreational cannabis would come with a five percent tax along with the state’s typical 6.5 percent sales tax. The sale of cannabis to patients with a written recommendation from a licensed specialist would not be taxed. The more interesting part about the Arkansas Cannabis Amendment is how devoted it is to home cultivation. Although it seems ridiculous, Arkansas may be the pioneer for legal marijuana in the south.

0 523

Form 10-Q/A for PAZOO, INC.


31-Mar-2016

Quarterly Report

Item 2 Management’s Discussion and Analysis of Financial Condition and Results of OperationsThis Quarterly Report on Form 10-Q contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements in this Quarterly Report that are not statements of historical facts are forward-looking statements, which involve risks and uncertainties. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions are intended to identify forward-looking statements. Our actual results may differ materially from those indicated in the forward-looking statements as a result of the factors set forth elsewhere in this Quarterly Report on Form 10-Q, including under “Risk Factors.” You should read the following discussion and analysis together with our unaudited financial statements for the periods specified and the related notes included herein. Further reference should be made to our Registration Statement on Form S-1 filed with the Securities and Exchange Commission.

This Quarterly Report on Form 10-Q contains terminology referring to Pazoo, Inc., such as “us,” “our,” and “the Company.”

Management intends the following discussion to assist in the understanding of our financial position and our results of operations for the three months and six months ended June 30, 2015 and June 30, 2014.

Overview
Pazoo (“Pazoo”) was incorporated in Nevada on November 16, 2010 under the name “IUCSS, Inc.” A name change from IUCSS, Inc. to Pazoo occurred on May 9, 2011. We are a health and wellness company. Presently, our primary business is Pazoo.com, an online, content driven, ad supported health and wellness web site for people and their pets. Additionally, this site has e-commerce functionality which allows Pazoo.com to be an online retailer of nutritional foods/supplements, wellness goods, and fitness apparel. Pazoo, Inc. does not have any brick and mortar establishments. At present our only revenue source is www.pazoo.com which generates product sales and online advertising revenue. As of June 30, 2015, we had total assets of $2,299,761 and plan to make additional investments in online content.

Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee’s and MA’s license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill’s top-rated testing protocols in select markets as we expand throughout the USA. Pazoo’s subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com.

Our principal executive offices are located at 760 Route 10, Suite 203, Whippany, New Jersey 07981. Our telephone number is (855) PAZOO-US. Our internet address is www.pazoo.com.

Sources of Revenue
We currently have three lines of business relating to and revolving around the health and wellness arena:

? Advertising Revenue from Our Website, www.pazoo.com. Through advertising providers and agencies, pazoo.com is paid for every ad impression that appears on a page for which a visitor goes to. As we build our visitor base, ad revenue will increase. However, just having the traffic does not effectively increase advertising revenue. To get the full value of each visitor, the time on site must be long enough so that a visitor is interested in going to multiple pages for which there are ads on each page. The only way this will transpire is if the visitor’s experience is gratifying. This is why pazoo.com is so focused on quality content that’s interesting and informative. A bad visitor experience will result in a low time on site and fewer page views. Internet tracking tools have much improved over the past decade and will continue to improve in the coming years, especially when it comes to advertising and overall website analytics. Pazoo continues to constantly improve is this area at all times.

Pazoo.com has a unique and compelling online marketing platform. Pazoo.com offers the following important marketing advantages to its target audiences:

1. A comprehensive solution as a content source – information on a full spectrum of disciplines within the health and wellness marketplace;

2. Health and wellness experts that have expertise in these varied disciplines and write about their areas expertise; and

3. Content that is both for the health and wellness of people as well as their pets (over 60% of American homes have pets).


Table of Contents
? E-commerce. Our e-commerce offerings will increase as we build the traffic coming to pazoo.com. In this way we could establish a revenue source over and above advertising to increase the value of each visitor. We have the following e-commerce elements ready for an activated marketing program:

1. An e-commerce platform that is functional;

2. Relationships with manufacturers, distributors and other e-commerce companies so that increasing product offerings will not be time consuming;

3. Members on the pazoo.com content team with merchandising experience: i.e. a Pazoo expert is buyer of pet products for a large pet retailer; and

4. Members on the pazoo.com content team that are experienced in e-commerce marketing; i.e. we will look to offer our consumers low cost and timely delivery of product by negotiating with shipping companies to offer a flat rates on various products.

? Pharmaceutical Testing Facilities. We entered this arena through our April 2014 acquisition of a 40% minority equity stake in MA & Associates, LLC. MA & Associates was launched in September of 2013 to provide quality control services to the medical cannabis industry. MA & Associates’ primary mission is to protect the public health by providing infrastructure and analytical services to legally authorized distributors and producers of cannabis and to regulators tracking their operations. As of June, 2015, we have acquired a 100% equity state in MA & Associates, LLC and the testing laboratory in Las Vegas Nevada is open for business.

The company will provide the medical cannabis industry guidelines on how the regulation and inspection by public health authorities is to be implemented. MA & Associates’ primary customer base includes all of the licensed cannabis cultivators, in the State of Nevada, and their customers are required by law to have their products tested before they can be transferred to the dispensaries.

We have further expanded our footprint in this arena through our acquisition of 100% stake in Harris Lee Holdings, LLC, a company formed to take the MA & Associates testing model outside of Nevada and into other states. The company is currently in the process of partnering with Harris Lee Colorado, LLC to take over an existing lab in Denver, Colorado, and just announced it has leased a space in Portland, Oregon where it will be establishing a testing lab. We are in a unique position to provide the mandated health and safety testing upon which this burgeoning industry must hinge moving forward.

Critical Accounting Policy and Estimates Our financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. On an on-going basis, management evaluates its estimates and judgments, including those related to revenue recognition, accrued expenses, financing operations, and contingencies and litigation. Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Results of Operations
Comparison of the three months ended June 30, 2015 to the three months ended June 30, 2014

Net Sales. We had net sales of $1,399 and $34,093 in the three months ended June 30, 2015 and June 30, 2014, respectively.

Cost of Goods Sold. We had cost of goods sold of zero and $244 in the three months ended June 30, 2015 and June 30, 2014, respectively.

Operating Expenses. Operating expenses consisted primarily of selling, general and administrative expenses and professional fees. Total operating expenses increased to $750,227 for the three month period ended June 30, 2015 from $492,211 for the three month period ended June 30, 2014. The components of operating expenses are detailed below.

Selling, General and Administrative expenses increased to $401,921 from $320,808, in 2015 versus 2014 which was mainly comprised of professional fees, stock compensation, and marketing & advertising.

Professional fees increased to $299,035 from $136,701 in 2015 versus 2014. The increase in professional fees was attributed to an increase in investor relations and investor consultants.


Table of Contents
Net Loss. Our net loss increased to $2,297,246 for the three months ended June 30, 2015 from $503,249 for the same period in 2014. The increase is primarily attributable to higher operating expense, as outlined above.

Results of Operations
Comparison of the six months ended June 30, 2015 to the six months ended June 30, 2014

Net Sales. We had net sales of $21,632 and $51,419 in the six months ended June 30, 2015 and June 30, 2014, respectively.

Cost of Goods Sold. We had cost of goods sold of zero and $569 in the six months ended June 30, 2015 and June 30, 2014, respectively.

Operating Expenses. Operating expenses consisted primarily of selling, general and administrative expenses and professional fees. Total operating expenses increased to $2,116,730 for the six month period ended June 30, 2015 from $834,283 for the six month period ended June 30, 2014. The components of operating expenses are detailed below.

Selling, General and Administrative expenses increased to $1,482,783 from $605,039, in 2015 versus 2014 which was mainly comprised of professional fees, stock compensation, and marketing & advertising.

Professional fees increased to $527,556 from $172,134 in 2015 versus 2014. The increase in professional fees was attributed to an increase in investor relations and investor consultants.

Net Loss. Our net loss increased to $4,221,774 for the six months ended June 30, 2015 from $1,132,733 for the same period in 2014. The increase is primarily attributable to higher operating expense, as outlined above.

Liquidity and Capital Resources. In the six month period ended June 30, 2015, we had outstanding 667,848,681 common shares, 2,463,526 Series A Preferred Stock shares, 1,637,500 Series B preferred stock, and 1,080,000 shares of Series C Preferred Stock shares to fund business operations and invest in companies.

Our total assets were $2,299,761 as of June 30, 2015, which primarily consisted of goodwill, intangible assets and accounts receivable primarily for advertising revenue.

We had negative working capital of $2,713,250 as of June 30, 2015.

Our total liabilities were $4,311,103 which was mainly comprised of derivative liabilities of $1,542,994, convertible debt of $1,152,240 and contingent consideration liabilities of $1,228,581.

Our total stockholder’s deficit as of June 30, 2015 was $2,011,343 and we had a retained deficit of $11,641,724 through the same period.

We used $1,067,321 in net cash for operating activities for the six months ended June 30, 2015, which included a net loss of $4,221,774 and gain on derivative liability of $6,031.

We had $1,084,341 net cash used in investing activities in the six month period ended June 30, 2015 due primarily to investment in MA & Associates.

We had $1,570,667 net cash provided by financing activities in the six month period ended June 30, 2015 due primarily to borrowings on convertible notes and proceeds from sale of Series A preferred stock and warrants.

As of June 30, 2015, we had no formal long-term lines of credit or bank financing arrangements.

Off-Balance Sheet Arrangements. We have no off-balance sheet arrangements.

Subsequent Events.

In accordance with FASB ASC 855-10-50-1 we evaluated our subsequent events through August 14, 2015. Refer to Note 9, Subsequent Events, for detailed information.


Table of Contents

0 1493

On this week’s “IT’S TIME!” show Buffer’s guest is none other than Mills and Buffer, who is the Founder of MED-X, Inc., as well as the COO,  which is a company that is taking advantage of the booming Marijuana industry in the United States at full force with products that offer effective nontoxic and 100% all-natural pest management for marijuana growers. These same products today are being utilized and spread throughout the pest control and hospitality sector nationally. Mills and Buffer also talked about the unique business ventures MED-X offers thru StartEngine.com allowing potential investors to get in on the action and purchase shares of the stock in the company. With a very interesting interview that displayed the flip side of the coin and how a new creative business can be set into motion in America today in a way that was not available to entrepreneurs just a few years ago.

https://soundcloud.com/itstimewithbrucebuffer/medxs-matthew-mills-discusses-the-booming-cannibus-industry-in-america-with-bruce-buffer

www.startengine.com/startup/med-x

0 622

 

There are just five more months before medical cannabis outlets can be opened in Hawaii. However, business owners may still be seeing obstacles that have not been seen before in the archipelago. Dispensaries can open during the middle of July. However, industry experts state that they may be confronted with challenged that those in other states do not need to face. For instance, there are concerns over trade over the water and such. Also, there are not many labs to test crops at which is another issue state lawmakers must deal with.

“Hawaii is going to be a really interesting market in general, basically because of the geography,” Chris Walsh, managing editor of Marijuana Business Daily, stated. “First, it’s a chain of islands separated by bodies of water, and second, it’s remote.”

At the moment, the Hawaii Department of Health is looking at dispensary applications, and will likely begin giving out licenses in April. Woody Harrelson, an actor, and huge cannabis activist, as well Henk Rogers, a video game designer, are one of the fifty-nine residents who applied for licenses. Thanks to a law passed in 2015, Hawaii will give out eight licenses to cannabis businesses, each of which will be able to have two production centers and two dispensaries. Three licenses “will be awarded for Oahu, two for Hawaii Island, two for Maui and one for Kauai.”

The same law did not allow for inter-island trade. Cannabis activists state that this will separate the industry into unique economies on each part of the archipelago, which is unique to just Hawaii. Also, there could be cannabis shortages, and even not allow some businesses to sell cannabis until laboratories are allowed.

All medical cannabis must be examined in a laboratory approved by the state before it is distributed. However, there are none in the state of islands. Some are concerned that expensive startups and low patient numbers will not allow laboratories to be approved.

“Clearly, not every island can support a full-on laboratory,” Pam Lichty, president of the Drug Policy Action Group, stated.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements